Instil Bio (TIL) Stock Highlights

20.61 | +2.64%

2024-12-21 06:21:23

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing an innovative cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using our Co-Stimulatory Antigen Receptor, or CoStAR, platform. The companys lead product candidate, ITIL-168, is an autologous TIL therapy that it is initially developing for the treatment of PD-1-inhibitor relapsed or refractory advanced melanoma.

Statistics

Range Today

19.12 21.9

Volume Today 127.9K

Range 1 Year

6.72 92

Volume 1 Year 25.4M

Range 3 Year

6.08 379.4

Volume 3 Year 41.97M

Range 10 Year

6.08 589.8

Volume 10 Year 45.75M

Highlights

Market Capitalization 200.58M (small)

Floating Shares 2.37M

Current Price 20.61

Price To Earnings -1.46

Price To Book 1.03

Earnings Per Share -19.94

Payout Ratio 0%

Performance

Latest +2.64%

1 Month -20.46%

3 Months -65.13%

6 Months +114.24%

1 Year +185.85%

3 Years -93.42%

5 Years -96.18%

10 Years -96.18%

Benchmarks

Market Capitalization

273 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

162 / 368

Free Cashflow

295 / 352

Performance 5 years

331 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.